Edwards oximetry central venous catheter continuously monitors central venous oxygen saturation (Scv02), an early indicator of compromised or inadequate oxygen delivery. By providing a more sensitive indicator of oxygen imbalance, Edwards oximetry central venous catheter identifies critical changes earlier than traditional vital signs and intermittent sampling— enabling you to recognize and prevent tissue hypoxia sooner. 1-5

Edwards oximetry
central venous catheter

Continuous ScvO2 monitoring – The clarity in an early warning of oxygen imbalance.

Edwards oximetry central venous catheter – the first proven central venous catheter with continuous ScvO2 monitoring – reveals the true adequacy of tissue oxygenation for clarity in early assessment and intervention.1–5

Edwards oximetry central venous catheter with integrated Oligon antimicrobial protection.

Edwards oximetry central venous catheter with integrated Oligon†† antimicrobial protection (For use in the U.S. only)

Edwards oximetry central venous catheter

Edwards oximetry central venous catheter

Helps guide therapy and provide real-time insight into the efficacy of intervention.1,2,6

Continuous ScvO2 monitoring enables proactive management of tissue hypoxia:1–5

  • Reveals the root cause of oxygen imbalance, enabling you to determine appropriate therapy early.1,7
  • Allows for immediate assessment of patient’s clinical response to therapy.1,2,6
  • Helps you stay ahead of tissue hypoxia and stages of sepsis.8–11

Convenient, accurate and easy to use

  • Uses same insertion techniques as that of central lines.
  • Offers continuous ScvO2 monitoring, pressure monitoring and fluid resuscitation.
  • Provides accurate oxygenation status.1

Edwards oximetry central venous catheter brochure

Model numbers

LumensLength (CM)Oligon
X3816KT 3 16
X3820KT 3 20
XA3816KT 3 16 X
XA3816SAFKT 3 16 X
XA3820KT 3 20 X
XA3820SAFKT 3 20 X

The advantages of antimicrobial protection and high-pressure injection, together in a single device.

Integrated Oligon antimicrobial protection

Continuous ScvO2 monitoring is also available with integrated Oligon antimicrobial†† material, which releases silver ions (Ag+) from an integrated polymer that will not wash away like antimicrobial coatings. Integrated Oligon antimicrobial material provides enduring antimicrobial protection. Silver ions (Ag+) are released at a stable rate to attack microbes, alter cell DNA and disrupt cell reproduction.

  • Protects against gram-negative and gram-positive bacteria, fungi and resistant microorganism strains.12–14

High-pressure injection capability with the Edwards oximetry central venous catheter is indicated for high-pressure injection of high-contrast media for visualization under imaging modalities such as CT, MRI, and fluoroscopy.12 (For use with Oligon models only)

††The activity of the antimicrobial agent is localized at the catheter surfaces and is not intended for treatment of systemic infections. In vitro testing demonstrated that the Oligon material provided broad–spectrum effectiveness (≥ 3 log reduction from initial concentration within 48 hours) against the organisms tested: Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Enterococcus faecalis, Candida albicans, Escherichia coli, Serratia marcescens, Acinetobacter calcoaceticus, Corynebacterium diphtheriae, Enterobacter aerogenes, GMRSa, Pseudomonas aeruginosa, Candida glabrata and VRE (Enterococcus faecium).
Edwards oximetry catheter Edwards Oximetry central venous catheter with integrated Oligon†† antimicrobial protection (For use in the U.S. only)
Clinical application

Early assessment with real-time ScvO2 monitoring enables proactive clinical decisions for your high-risk patients.1–5

Continuous ScvO2 monitoring is key to assessing the adequacy of the balance of oxygen delivery and consumption. The goal of continuous ScvO2 monitoring with the Edwards oximetry central venous catheter is to bring into balance the relationship between oxygen delivery and consumption to help improve the care of high-acuity patients.17

Demonstrated prognostic value of continuous ScvO2 monitoring can be seen in:

  • Post-op high-risk surgeries18
  • Trauma4
  • Sepsis19
  • Cardiac failure in congenital heart failure5
  • Recovery in cardiac arrest20,21

Continuous ScvO2 monitoring has multiple applications in intra- and post-op stages including:22,23

  • Risk for high blood loss, such as hepatic resections, trauma, vascular cases
  • High fluid shifts in gastrointestinal cases
  • Toleration of single-lung ventilation in thoracic procedures
  • Early indication of failure to tolerate extubation

Hemodynamic Trends

Continuous measurement of ScvO2 can be used as a reliable monitor of cardiocirculatory function.
Continuous ScvO2 monitoring reveals reveals the root cause of oxygen imbalance, enabling you to determine appropriate therapy.
Balance of oxygen delivery and consumption for high-risk surgical, intensive care and surgical patients.
Continuous measurement of ScvO2 can be used as a reliable monitor of cardiocirculatory function.
Continuous ScvO2 monitoring reveals reveals the root cause of oxygen imbalance, enabling you to determine appropriate therapy.
Balance of oxygen delivery and consumption for high-risk surgical, intensive care and surgical patients.

Edwards Lifesciences hemodynamic monitoring solutions offer advanced flow-based parameters to help you detect sepsis early, guide treatment evaluation, and comply with NQF/CMS bundle requirements.

Learn more about Sepsis management

View the Sepsis bundle guidelines overview

Request a copy close
Edwards clinical education

Hemodynamic education empowering clinical advancement

With a long-term commitment to improving the quality of care for surgical and critical care patients through education, Edwards clinical education meets you no matter where you are in the learning process — with a continuum of resources and tools that continuously support you as you solve the clinical challenges facing you today, and in the future.

For more educational information

Product implementation

Compatible Monitoring Platforms

HemoSphere advanced
monitoring platform

HemoSphere advanced monitoring platform

HemoSphere setup guide

EV1000
clinical platform

EV1000 clinical platform

EV1000 setup guide

Related Products

ClearSight system

ClearSight system

Learn more
FloTrac system

FloTrac system

Learn more
PediaSat oximetry catheter

PediaSat oximetry catheter

Learn more
Contact us

The Edwards Advantage

We are committed to providing your institution, clinicians and staff with the highest levels of customer service and support to ensure seamless product implementation and ongoing use, including:

  • 24/7 technical support – Simply call 800-822-9837 anytime, day or night
  • Customer service – Call 800-424-3278 to speak to a customer service representative

Contact a sales representative

References:
  1. Reinhart K, et al. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med. 2004;30(8):1572-8.
  2. Rivers EP, et al. Central venous oxygen saturation monitoring in the critically ill patient. Curr Opin Crit Care. 2001;7(3):204-11.
  3. Ingelmo P, et al. Importance of monitoring in high risk surgical patients. Minerva Anestesiol. 2002;68(4):226-30.
  4. Scalea, TM, et al. Central venous oxygen saturation: a useful clinical tool in trauma patients. J Trauma 1990;30(12):1539-43.
  5. Ander, DS, et al. Undetected cardiogenic shock in patients with congestive heart failure presenting to the emergency department. Am J Cardiol 1998;82(7):888-91.
  6. Tweddell, JS, et al. Mixed venous oxygen saturation monitoring after stage 1 palliation for hypoplastic left heart syndrome. Ann Thorac Surg 2007;84:1301-1311
  7. Zaja J. Venous oximetry. Signa Vitae 2007;2(1):6-10.
  8. Spenceley, N., et al. Continuous central venous saturations during pericardial tamponade case report. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.153.
  9. Krahn, G., et al. Early clinical evaluation of the Edwards PediaSat™ oximetry catheter in pediatric patients. Pediatr Crit Care Med 2007,Vol. 8,No. 3,p18.2.152.
  10. Spenceley, N., et al. Continuous central venous saturation monitoring in pediatrics: a case report. Pediatr Crit Care Med 2008, Vol. 9, No. 2, p e13-e16
  11. Lemson et al. Advanced hemodynamic monitoring in critically ill patients. Pediatrics. 2011
  12. GOV FDA 510k EOCVC (K160645)
  13. Edwards Oligon Oximetry Catheters contain an integrated Oligon antimicrobial material. The activity of the antimicrobial agent is localized at the catheter surfaces and is not intended for treatment of systemic infections. In vitro testing demonstrated that the Oligon material provided broad-spectrum effectiveness (= 3 log reduction from initial concentration within 48 hours) against the organisms tested: Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Enterococcus faecalis, Candida albicans, Escherichia coli, Serratia marcescens, Acinetobacter calcoaceticus, Corynebacterium diphtheriae, Enterobacter aerogenes, GMRSa, Pseudomonas aeruginosa, Candida glabrata and VRE (Enterococcus faecium).
  14. US Patent #4411648
  15. Ranucci M, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003;31(1):52-9.
  16. Garcia, R, et al. Three years experience in implementing HICPAC recommendations for the reduction of central venous catheter-related bloodstream infections. Poster presentation at National APIC meeting, June 2003.
  17. Loren D. Continuous venous oximetry in surgical patients. Ann Surg. 1986;203/3:329-333.
  18. Pearse, R, et al. Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005;9(6):R694-91.
  19. Rady, MY, et al. Resuscitation of the critically ill in the ED: responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate. Am J Emerg Med 1996;14(2):218-25.
  20. Rivers, EP, et al. The clinical implications of continuous central venous oxygen saturation during human CPR. Ann Emerg Med 1992;21(9):1094-101.
  21. Nakazawa, K, et al. Usefulness of central venous oxygen saturation monitoring during cardiopulmonary resuscitation. A comparative case study with end-tidal carbon dioxide monitoring. Intensive Care Med 1994;20(6):450-1.
  22. Noguiera P, et al. Central Venous Saturation: A Prognostic Tool in Cardiac Surgery Patients. J Intensive Care Med. 2010;25(2):111-116.
  23. Vallet B, et al. Venous oxygen saturation as a physiologic transfusion trigger. Crit Care. 2010;14:213.
  24. Donati A, et al. Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk patients. Chest. 2007;132:1817-1824.
  25. Marik P, et al. Does central venous pressure predict fluid responsiveness? A systemic review of the literature and the Tale of Seven Mares. Chest. 2008;134;172–178

Important safety information

Caution: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Important safety information

Caution: Federal (United States) law restricts this device to sale by or on the order of a physician.
See Instructions For Use (IFU) / Directions For Use (DFU) for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Please update your browserClose this window

Please update to a current version of your preferred browser, this site will perform effectively on the following:

Internet Explorer Google Chrome Safari Firefox
Unable to update your browser?

If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility